Product NDC: | 50564-544 |
Proprietary Name: | Digoxin |
Non Proprietary Name: | Digoxin |
Active Ingredient(s): | 125 ug/1 & nbsp; Digoxin |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50564-544 |
Labeler Name: | Jerome Stevens Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076268 |
Marketing Category: | ANDA |
Start Marketing Date: | 20020726 |
Package NDC: | 50564-544-10 |
Package Description: | 1000 TABLET in 1 BOTTLE (50564-544-10) |
NDC Code | 50564-544-10 |
Proprietary Name | Digoxin |
Package Description | 1000 TABLET in 1 BOTTLE (50564-544-10) |
Product NDC | 50564-544 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Digoxin |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20020726 |
Marketing Category Name | ANDA |
Labeler Name | Jerome Stevens Pharmaceuticals, Inc. |
Substance Name | DIGOXIN |
Strength Number | 125 |
Strength Unit | ug/1 |
Pharmaceutical Classes | Cardiac Glycoside [EPC],Cardiac Glycosides [Chemical/Ingredient] |